StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Axis Securities

BUYRainbow Childrens Medicare Limited

byAxis SecuritiesHorizon: NA (inferred 1 year)30 Sept 2025via Institutional / Brokerage Research

Entry₹1,356Inferred
Target₹1,625
Total upside +19.84%
Stop lossNot given
CMP₹1,449.9Just now
Active+6.92%+12.08%upside left 3 wk left
Follow Axis Securities for new calls(70% target hit, 855 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alertsSee 5 other Long-term calls on RAINBOWSee 72 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 4:25 pm IST
10 supporting3 neutral3 opposing
Supports the BUY call (10)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·25 Aug · 2w ago

India’s most profitable hospitals: Max, Apollo and others — who ranks on top?

NewsCnbc-Tv18·19 Aug · 3w ago

(opens in new tab)

Rainbow Children's Medicare Ltd has completed the acquisition of 64% of the partnership interest and capital contribution in Super Prime Medical Care LLP.

BSE · Company Update·14 Aug · 4w ago

(opens in new tab)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·4 Aug · 1mo ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·7 Sept · yesterday

Mr. Vikas Maheshwari has resigned as Chief Financial Officer of Rainbow Children's Medicare Ltd, effective August 31, 2026.

BSE · Company Update·25 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.